首页> 美国卫生研究院文献>Oncotarget >A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer

【2h】

A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer

机译：吉非替尼联合放疗联合化疗治疗无法手术的III期非小细胞肺癌患者的II期开放标签多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundGefitinib is an oral EGFR tyrosine kinase inhibitors which may act as a radiosensitizer.

机译：背景吉非替尼是一种口服EGFR酪氨酸激酶抑制剂，可作为放射增敏剂。

著录项

期刊名称 Oncotarget
作者
Antonin Levy; Etienne Bardet; Benjamin Lacas; Jean-Pierre Pignon; Julien Adam; Ludovic Lacroix; Xavier Artignan; Pierre Verrelle; Cécile Le Péoux;
展开▼
作者单位

展开▼
年(卷),期 2017(8),9
年度 2017
页码 15924–15933
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;细胞生物学;
关键词
iressa thoracic radiotherapy lung cancer phase II trial;

机译：易瑞沙;胸腔放疗;肺癌;II期试验;

相似文献

外文文献
中文文献
专利

1. Gefitinib in combination with irradiation with or without cisplatin in patients with inoperable stage III non-small cell lung cancer: a phase I trial. [J] . Rothschild S, Bucher SE, Bernier J, International Journal of Radiation Oncology, Biology, Physics . 2011,第1期

机译：吉非替尼联合放疗联合或不联合顺铂治疗无法手术的III期非小细胞肺癌患者：I期试验。
2. A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer [J] . RamalingamS.S., KotsakisA., TarhiniA.A., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2013,第3期

机译：西妥昔单抗联合胸部放疗和巩固化疗对III期非小细胞肺癌患者的多中心II期研究
3. Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study [J] . Zhiwei Chen, Shengping Shen, Wenbo Shi, Cancer Management and Research . 2019,第4期

机译：Intercalated化疗和欧洲替代阶段非小细胞肺癌的组合：多中心，开放标签，单臂，II期研究
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. A Phase I/II Radiation Dose Escalation Study with Concurrent Chemotherapy for Patients with Inoperable Stages I-III Non-Small Cell Lung Cancer: The Phase I Results of RTOG 0117 [O] . Jeffrey D. Bradley, Jennifer Moughan, Mary V. Graham, -1

机译：一种相位I / II放射剂量升级研究同时化疗患者I-III非小细胞肺癌I-III不小的细胞肺癌：ITOG 0117的阶段结果
7. Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer. [O] . Zatloukal, Petr, Gervais, Radj, Vansteenkiste, Johan, 2008

机译：拉罗他赛（XRP9881）联合顺铂或吉西他滨作为一线化疗在非照射性IIIB期或IV期非小细胞肺癌中的随机多中心II期研究。

A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅